UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000007994
Receipt No. R000009141
Scientific Title Evaluation of overexpression of VEGF mRNA of pancreatic cancer using surgical and endoscopic samples obtained with EUS-FNA
Date of disclosure of the study information 2012/05/21
Last modified on 2012/05/21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of overexpression of VEGF mRNA of pancreatic cancer using surgical and endoscopic samples obtained with EUS-FNA
Acronym The expression of VEGF mRNA of pancreatic cancer
Scientific Title Evaluation of overexpression of VEGF mRNA of pancreatic cancer using surgical and endoscopic samples obtained with EUS-FNA
Scientific Title:Acronym The expression of VEGF mRNA of pancreatic cancer
Region
Japan

Condition
Condition pancreatic cancer
Classification by specialty
Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To evaluate the overexpression of the VEGF mRNA of pancreatic cancer using surgical and endoscopic specimens obtained with EUS-FNA
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Evaluation of VEGF of pancreatic cancer using surgical and endoscopic samples
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Gene
Interventions/Control_1 Evaluation of VEGF mRNA and protein
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.The patients who are suspected of pancreatic cancer and have a plan to take the examination of EUS-FNA.

2.Performance status; 0,1,2
Key exclusion criteria 1.The patients who take anticoagulants
2.The patients with acute pancreatitis
3.The patient who have already take chemotherapy or radiotherapy
4.The patients who are pregnant
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Akira Dobashi
Organization The Jikei University School of Medicine
Division name Department of Endoscopy
Zip code
Address 3-25-8 Nishi Shinbashi, Minato-ku, Tokyo 105-8461, Japan
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name
Organization The Jikei University School of Medicine
Division name Department of Endoscopy
Zip code
Address
TEL 03-3433-1111
Homepage URL
Email rinri@jikei.ac.jp

Sponsor
Institute The Jikei University School of Medicine
Institute
Department

Funding Source
Organization Research fund of The Jikei University School of Medicine, Department of Endoscopy.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京慈恵会医科大学

Other administrative information
Date of disclosure of the study information
2012 Year 05 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2011 Year 09 Month 09 Day
Date of IRB
Anticipated trial start date
2012 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2012 Year 05 Month 21 Day
Last modified on
2012 Year 05 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009141

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.